Interpace Biosciences Inc (IDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,505 | 1,461 | 3,498 | 4,828 | 2,922 |
| Receivables | 5,649 | 8,544 | 5,078 | 5,032 | 4,672 |
| Other current assets | 1,746 | 1,768 | 1,841 | 2,294 | 4,572 |
| TOTAL | $9,900 | $11,773 | $10,417 | $12,154 | $12,166 |
| Non-Current Assets | |||||
| PPE Net | 1,423 | 1,361 | 790 | 480 | 317 |
| Intangibles | 0 | 0 | 0 | 861 | 2,132 |
| Other Non-Current Assets | 22,515 | 1,658 | 1,909 | 2,484 | 23,812 |
| TOTAL | $23,938 | $3,019 | $2,699 | $3,825 | $26,261 |
| Total Assets | $33,838 | $14,792 | $13,116 | $15,979 | $38,427 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 0 | 2,500 | N/A |
| Accounts payable and accrued liabilities | 983 | 1,659 | 1,544 | 1,050 | 1,374 |
| Accrued Expenses | 1,886 | 2,207 | 1,969 | 1,456 | 2,689 |
| TOTAL | $5,103 | $10,615 | $11,436 | $14,283 | $15,682 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 4,243 | 11,165 | 9,442 |
| Other Non-Current Liabilities | 6,372 | 6,394 | 52,976 | 53,603 | 55,721 |
| TOTAL | $6,372 | $6,394 | $57,219 | $64,768 | $65,163 |
| Total Liabilities | $11,475 | $17,009 | $68,655 | $79,051 | $80,845 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,701 | 4,423 | 4,376 | 4,311 | 4,226 |
| Common Shares | 407 | 406 | 405 | 405 | 403 |
| Retained earnings | -210,805 | -235,380 | -242,082 | -249,017 | -227,059 |
| Other shareholders' equity | -72 | -54 | -8 | 24 | 132 |
| TOTAL | $22,363 | $-2,217 | $-55,539 | $-63,072 | $-42,418 |
| Total Liabilities And Equity | $33,838 | $14,792 | $13,116 | $15,979 | $38,427 |